Realyze Intelligence
The business, the turning points, and the decisions behind them.
Some sections are still being researched2 / 4
Sections to complete：02 · 05
01 / WHAT IT BUILT
What the company did
Realyze Intelligence was a healthcare AI company launched in June 2021 as a spin-out of UPMC's innovation arm, UPMC Enterprises. Founded by Gilan El Saadawi and Aaron Brauser, it built a clinical-intelligence platform that used artificial intelligence and natural language processing to 'read' both the structured data and the descriptive clinical notes inside patients' electronic medical records. By decoding each patient's story, the platform identified precisely defined populations with chronic diseases and cancer, linked them to the most beneficial treatments, and was later used to match patients to clinical trials and research studies. It partnered with clinical-data company Q-Centrix in cardiology and oncology.
02 / FAILURE REASONS
Material for this section is being gathered and checked. It will appear here once ready.
03 / EVENT HISTORY
Events in the structured record
- Launched
UPMC Enterprises launched Realyze Intelligence, an AI clinical-intelligence platform for chronic disease and cancer patients; pilots at UPMC analyzed more than 100,000 chronic kidney disease patients.
- Acquired
Carta Healthcare acquired Realyze Intelligence from UPMC Enterprises to strengthen its AI clinical-data platform, including patient matching for clinical trials.
04 / CONTEMPORARY REBUILD ASSESSMENT
Difficulty of rebuilding this project today
Material for this section is being gathered and checked. It will appear here once ready.
Overall assessment: Not completed
05 / CAUSAL CHAIN / AFTERMATH
Material for this section is being gathered and checked. It will appear here once ready.